User profiles for Marisa Hom
Marisa HomResearch Assistant Professor Verified email at vumc.org Cited by 138 |
Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1
Z Feng, ME Hom, TE Bearrood, ZC Rosenthal… - Nature chemical …, 2022 - nature.com
Aldehyde dehydrogenases (ALDHs) are promising cancer drug targets, as certain isoforms
are required for the survival of stem-like tumor cells. We have discovered selective inhibitors …
are required for the survival of stem-like tumor cells. We have discovered selective inhibitors …
[HTML][HTML] EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
Rationale: First-line therapy for high-grade gliomas (HGGs) includes maximal safe surgical
resection. The extent of resection predicts overall survival, but current neuroimaging …
resection. The extent of resection predicts overall survival, but current neuroimaging …
[HTML][HTML] The evolution of fluorescence-guided surgery
S Van Keulen, M Hom, H White, EL Rosenthal… - Molecular Imaging and …, 2023 - Springer
There has been continual development of fluorescent agents, imaging systems, and their
applications over the past several decades. With the recent FDA approvals of 5-aminolevulinic …
applications over the past several decades. With the recent FDA approvals of 5-aminolevulinic …
First clinical results of fluorescence lifetime-enhanced tumor imaging using receptor-targeted fluorescent probes
Purpose: Fluorescence molecular imaging, using cancer-targeted near infrared (NIR)
fluorescent probes, offers the promise of accurate tumor delineation during surgeries and the …
fluorescent probes, offers the promise of accurate tumor delineation during surgeries and the …
A scoping review of ongoing fluorescence‐guided surgery clinical trials in otolaryngology
KL Crawford, FV Pacheco, YJ Lee, M Hom… - The …, 2022 - Wiley Online Library
Objective Fluorescence‐guided surgery (FGS) is a rapidly developing intraoperative
technology, and many contrast agents are currently under investigation. We sought to provide a …
technology, and many contrast agents are currently under investigation. We sought to provide a …
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma
Purpose: Determine the safety and specificity of a tumor-targeted radiotracer ( 89 Zr-pan) in
combination with 18 F-FDG PET/CT to improve diagnostic accuracy in head and neck …
combination with 18 F-FDG PET/CT to improve diagnostic accuracy in head and neck …
Factors for differential outcome across cancers in clinical molecule-targeted fluorescence imaging
…, MA Engelen, YJ Lee, M Hom… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Clinical imaging performance using a fluorescent antibody was compared across 3 cancers
to elucidate physical and biologic factors contributing to differential translation of epidermal …
to elucidate physical and biologic factors contributing to differential translation of epidermal …
Efficacy of Depatuxizumab Mafodotin (ABT-414) in preclinical models of head and neck cancer
…, A Naveed, A McAdoo, E Rosenthal, M Hom - …, 2024 - academic.oup.com
Epidermal growth factor receptor (EGFR) is highly expressed in 80-90% of head and neck
squamous cell carcinomas (HNSCCs), making it an ideal target for antibody-drug conjugates (…
squamous cell carcinomas (HNSCCs), making it an ideal target for antibody-drug conjugates (…
Bicyclic imidazolium inhibitors of Gli transcription factor activity
Gli transcription factors within the Hedgehog (Hh) signaling pathway direct key events in
mammalian development and promote a number of human cancers. Current therapies for Gli‐…
mammalian development and promote a number of human cancers. Current therapies for Gli‐…
[HTML][HTML] The use of panitumumab-IRDye800CW in a novel murine model for conjunctival squamous cell carcinoma
Purpose: Conjunctival squamous cell carcinoma (SCC) is a sight-threatening ocular surface
malignancy with the primary treatment modality being surgical resection. To evaluate …
malignancy with the primary treatment modality being surgical resection. To evaluate …